nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—NPPB—blood plasma—hepatitis B	0.0274	0.154	CbGeAlD
Carvedilol—SELE—blood plasma—hepatitis B	0.0185	0.104	CbGeAlD
Carvedilol—Respiratory disorder—Lamivudine—hepatitis B	0.0179	0.0397	CcSEcCtD
Carvedilol—VCAM1—blood plasma—hepatitis B	0.017	0.0958	CbGeAlD
Carvedilol—Respiration abnormal—Lamivudine—hepatitis B	0.0169	0.0374	CcSEcCtD
Carvedilol—Kidney function abnormal—Adefovir Dipivoxil—hepatitis B	0.0121	0.0268	CcSEcCtD
Carvedilol—NPPB—blood—hepatitis B	0.01	0.0565	CbGeAlD
Carvedilol—Glycosuria—Entecavir—hepatitis B	0.0074	0.0164	CcSEcCtD
Carvedilol—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.00722	0.016	CcSEcCtD
Carvedilol—SELE—blood—hepatitis B	0.00677	0.0381	CbGeAlD
Carvedilol—Cough increased—Adefovir Dipivoxil—hepatitis B	0.00639	0.0141	CcSEcCtD
Carvedilol—VCAM1—blood—hepatitis B	0.00623	0.0351	CbGeAlD
Carvedilol—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00615	0.0136	CcSEcCtD
Carvedilol—HIF1A—blood—hepatitis B	0.00599	0.0338	CbGeAlD
Carvedilol—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.00575	0.0127	CcSEcCtD
Carvedilol—SELE—liver—hepatitis B	0.0053	0.0298	CbGeAlD
Carvedilol—NDUFC2—blood—hepatitis B	0.00506	0.0285	CbGeAlD
Carvedilol—VCAM1—liver—hepatitis B	0.00487	0.0274	CbGeAlD
Carvedilol—Hypertriglyceridaemia—Lamivudine—hepatitis B	0.00483	0.0107	CcSEcCtD
Carvedilol—HIF1A—liver—hepatitis B	0.00469	0.0264	CbGeAlD
Carvedilol—GJA1—liver—hepatitis B	0.00455	0.0256	CbGeAlD
Carvedilol—Anaphylactoid reaction—Entecavir—hepatitis B	0.0045	0.00996	CcSEcCtD
Carvedilol—Renal impairment—Adefovir Dipivoxil—hepatitis B	0.00446	0.00988	CcSEcCtD
Carvedilol—Blood triglycerides increased—Lamivudine—hepatitis B	0.00424	0.00938	CcSEcCtD
Carvedilol—Blood creatinine increased—Entecavir—hepatitis B	0.00408	0.00903	CcSEcCtD
Carvedilol—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00398	0.00881	CcSEcCtD
Carvedilol—NDUFC2—liver—hepatitis B	0.00396	0.0223	CbGeAlD
Carvedilol—CYP1A2—blood plasma—hepatitis B	0.00389	0.0219	CbGeAlD
Carvedilol—Renal impairment—Telbivudine—hepatitis B	0.00376	0.00832	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00375	0.00829	CcSEcCtD
Carvedilol—CYP2C9—blood plasma—hepatitis B	0.00369	0.0208	CbGeAlD
Carvedilol—VEGFA—liver—hepatitis B	0.00359	0.0202	CbGeAlD
Carvedilol—Pain in extremity—Telbivudine—hepatitis B	0.00358	0.00792	CcSEcCtD
Carvedilol—ADRA2A—blood plasma—hepatitis B	0.00358	0.0201	CbGeAlD
Carvedilol—Hyperaesthesia—Lamivudine—hepatitis B	0.00354	0.00783	CcSEcCtD
Carvedilol—Migraine—Telbivudine—hepatitis B	0.00352	0.00779	CcSEcCtD
Carvedilol—CYP2E1—blood plasma—hepatitis B	0.0035	0.0197	CbGeAlD
Carvedilol—Upper respiratory tract infection—Entecavir—hepatitis B	0.0035	0.00774	CcSEcCtD
Carvedilol—Hyperglycaemia—Entecavir—hepatitis B	0.00339	0.00751	CcSEcCtD
Carvedilol—PTGS1—blood plasma—hepatitis B	0.00337	0.019	CbGeAlD
Carvedilol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00332	0.00735	CcSEcCtD
Carvedilol—Renal failure—Entecavir—hepatitis B	0.0033	0.0073	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00322	0.00713	CcSEcCtD
Carvedilol—Cramp muscle—Telbivudine—hepatitis B	0.00322	0.00713	CcSEcCtD
Carvedilol—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00322	0.00712	CcSEcCtD
Carvedilol—Haematuria—Entecavir—hepatitis B	0.0032	0.00708	CcSEcCtD
Carvedilol—Nasopharyngitis—Telbivudine—hepatitis B	0.0032	0.00708	CcSEcCtD
Carvedilol—XDH—liver—hepatitis B	0.0032	0.018	CbGeAlD
Carvedilol—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00315	0.00698	CcSEcCtD
Carvedilol—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00312	0.00691	CcSEcCtD
Carvedilol—Influenza—Telbivudine—hepatitis B	0.00309	0.00684	CcSEcCtD
Carvedilol—Viral infection—Lamivudine—hepatitis B	0.00307	0.0068	CcSEcCtD
Carvedilol—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00307	0.0068	CcSEcCtD
Carvedilol—Oedema peripheral—Entecavir—hepatitis B	0.00297	0.00657	CcSEcCtD
Carvedilol—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00293	0.0065	CcSEcCtD
Carvedilol—Hearing impaired—Lamivudine—hepatitis B	0.00292	0.00646	CcSEcCtD
Carvedilol—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00292	0.00646	CcSEcCtD
Carvedilol—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0029	0.00642	CcSEcCtD
Carvedilol—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00288	0.00638	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00287	0.00636	CcSEcCtD
Carvedilol—CYP3A4—blood plasma—hepatitis B	0.00281	0.0159	CbGeAlD
Carvedilol—CYP2D6—blood plasma—hepatitis B	0.00277	0.0156	CbGeAlD
Carvedilol—Immune system disorder—Entecavir—hepatitis B	0.00272	0.00602	CcSEcCtD
Carvedilol—Renal failure—Telbivudine—hepatitis B	0.00271	0.006	CcSEcCtD
Carvedilol—Wheezing—Lamivudine—hepatitis B	0.0027	0.00597	CcSEcCtD
Carvedilol—Alopecia—Entecavir—hepatitis B	0.00266	0.00589	CcSEcCtD
Carvedilol—Malnutrition—Entecavir—hepatitis B	0.00262	0.0058	CcSEcCtD
Carvedilol—Aplastic anaemia—Lamivudine—hepatitis B	0.00261	0.00577	CcSEcCtD
Carvedilol—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00256	0.00566	CcSEcCtD
Carvedilol—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00252	0.00558	CcSEcCtD
Carvedilol—Back pain—Adefovir Dipivoxil—hepatitis B	0.00247	0.00548	CcSEcCtD
Carvedilol—Hypoaesthesia—Telbivudine—hepatitis B	0.00246	0.00545	CcSEcCtD
Carvedilol—Pharyngitis—Telbivudine—hepatitis B	0.00246	0.00544	CcSEcCtD
Carvedilol—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00236	0.00523	CcSEcCtD
Carvedilol—Leukopenia—Entecavir—hepatitis B	0.00235	0.00519	CcSEcCtD
Carvedilol—Sleep disorder—Lamivudine—hepatitis B	0.00233	0.00515	CcSEcCtD
Carvedilol—Cough—Adefovir Dipivoxil—hepatitis B	0.00223	0.00494	CcSEcCtD
Carvedilol—Mediastinal disorder—Telbivudine—hepatitis B	0.00223	0.00494	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00222	0.00491	CcSEcCtD
Carvedilol—Injury—Lamivudine—hepatitis B	0.00219	0.00485	CcSEcCtD
Carvedilol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00218	0.00482	CcSEcCtD
Carvedilol—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00218	0.00482	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00216	0.00479	CcSEcCtD
Carvedilol—Malnutrition—Telbivudine—hepatitis B	0.00215	0.00477	CcSEcCtD
Carvedilol—Anaphylactic shock—Entecavir—hepatitis B	0.00214	0.00474	CcSEcCtD
Carvedilol—Infection—Entecavir—hepatitis B	0.00213	0.00471	CcSEcCtD
Carvedilol—Renal impairment—Lamivudine—hepatitis B	0.00212	0.00469	CcSEcCtD
Carvedilol—Back pain—Telbivudine—hepatitis B	0.00208	0.00461	CcSEcCtD
Carvedilol—Skin disorder—Entecavir—hepatitis B	0.00208	0.0046	CcSEcCtD
Carvedilol—Muscle spasms—Telbivudine—hepatitis B	0.00207	0.00458	CcSEcCtD
Carvedilol—Hypoglycaemia—Lamivudine—hepatitis B	0.00206	0.00457	CcSEcCtD
Carvedilol—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00204	0.00452	CcSEcCtD
Carvedilol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00203	0.00449	CcSEcCtD
Carvedilol—Ill-defined disorder—Telbivudine—hepatitis B	0.002	0.00442	CcSEcCtD
Carvedilol—ABCB1—blood plasma—hepatitis B	0.00199	0.0112	CbGeAlD
Carvedilol—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00199	0.0044	CcSEcCtD
Carvedilol—Migraine—Lamivudine—hepatitis B	0.00198	0.00439	CcSEcCtD
Carvedilol—Affect lability—Lamivudine—hepatitis B	0.00198	0.00439	CcSEcCtD
Carvedilol—Malaise—Telbivudine—hepatitis B	0.00194	0.0043	CcSEcCtD
Carvedilol—Insomnia—Entecavir—hepatitis B	0.00193	0.00428	CcSEcCtD
Carvedilol—Mood swings—Lamivudine—hepatitis B	0.00191	0.00423	CcSEcCtD
Carvedilol—Somnolence—Entecavir—hepatitis B	0.0019	0.00421	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.0019	0.00421	CcSEcCtD
Carvedilol—Dyspepsia—Entecavir—hepatitis B	0.00188	0.00417	CcSEcCtD
Carvedilol—Cough—Telbivudine—hepatitis B	0.00188	0.00416	CcSEcCtD
Carvedilol—Dehydration—Lamivudine—hepatitis B	0.00187	0.00415	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Entecavir—hepatitis B	0.00185	0.00409	CcSEcCtD
Carvedilol—Fatigue—Entecavir—hepatitis B	0.00184	0.00408	CcSEcCtD
Carvedilol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00184	0.00407	CcSEcCtD
Carvedilol—Myalgia—Telbivudine—hepatitis B	0.00183	0.00406	CcSEcCtD
Carvedilol—Chest pain—Telbivudine—hepatitis B	0.00183	0.00406	CcSEcCtD
Carvedilol—Arthralgia—Telbivudine—hepatitis B	0.00183	0.00406	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00182	0.00403	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00181	0.00402	CcSEcCtD
Carvedilol—Cramp muscle—Lamivudine—hepatitis B	0.00181	0.00402	CcSEcCtD
Carvedilol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00181	0.00402	CcSEcCtD
Carvedilol—Discomfort—Telbivudine—hepatitis B	0.00181	0.00401	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.0018	0.00399	CcSEcCtD
Carvedilol—Nasopharyngitis—Lamivudine—hepatitis B	0.0018	0.00399	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00178	0.00393	CcSEcCtD
Carvedilol—Gastrointestinal pain—Entecavir—hepatitis B	0.00175	0.00387	CcSEcCtD
Carvedilol—Influenza—Lamivudine—hepatitis B	0.00174	0.00386	CcSEcCtD
Carvedilol—ADRA1A—blood—hepatitis B	0.00172	0.0097	CbGeAlD
Carvedilol—Thrombocytopenia—Telbivudine—hepatitis B	0.00172	0.00381	CcSEcCtD
Carvedilol—Skin disorder—Telbivudine—hepatitis B	0.00171	0.00378	CcSEcCtD
Carvedilol—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00171	0.00378	CcSEcCtD
Carvedilol—Sweating increased—Lamivudine—hepatitis B	0.0017	0.00376	CcSEcCtD
Carvedilol—Body temperature increased—Entecavir—hepatitis B	0.00169	0.00374	CcSEcCtD
Carvedilol—Abdominal pain—Entecavir—hepatitis B	0.00169	0.00374	CcSEcCtD
Carvedilol—Bronchitis—Lamivudine—hepatitis B	0.00167	0.00371	CcSEcCtD
Carvedilol—KCNH2—blood—hepatitis B	0.00166	0.00937	CbGeAlD
Carvedilol—Pancytopenia—Lamivudine—hepatitis B	0.00165	0.00366	CcSEcCtD
Carvedilol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00165	0.00365	CcSEcCtD
Carvedilol—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00165	0.00365	CcSEcCtD
Carvedilol—ADRA2C—blood—hepatitis B	0.00164	0.00924	CbGeAlD
Carvedilol—Pollakiuria—Lamivudine—hepatitis B	0.00161	0.00356	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0016	0.00354	CcSEcCtD
Carvedilol—Insomnia—Telbivudine—hepatitis B	0.00159	0.00352	CcSEcCtD
Carvedilol—Paraesthesia—Telbivudine—hepatitis B	0.00158	0.00349	CcSEcCtD
Carvedilol—Hyperglycaemia—Lamivudine—hepatitis B	0.00157	0.00348	CcSEcCtD
Carvedilol—Depression—Lamivudine—hepatitis B	0.00155	0.00343	CcSEcCtD
Carvedilol—Dyspepsia—Telbivudine—hepatitis B	0.00155	0.00342	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00154	0.00341	CcSEcCtD
Carvedilol—Asthenia—Entecavir—hepatitis B	0.00153	0.0034	CcSEcCtD
Carvedilol—Renal failure—Lamivudine—hepatitis B	0.00153	0.00338	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00152	0.00336	CcSEcCtD
Carvedilol—Fatigue—Telbivudine—hepatitis B	0.00152	0.00335	CcSEcCtD
Carvedilol—Pain—Telbivudine—hepatitis B	0.0015	0.00333	CcSEcCtD
Carvedilol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0015	0.00332	CcSEcCtD
Carvedilol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00148	0.00327	CcSEcCtD
Carvedilol—Diarrhoea—Entecavir—hepatitis B	0.00146	0.00324	CcSEcCtD
Carvedilol—Sinusitis—Lamivudine—hepatitis B	0.00146	0.00323	CcSEcCtD
Carvedilol—Feeling abnormal—Telbivudine—hepatitis B	0.00145	0.00321	CcSEcCtD
Carvedilol—Gastrointestinal pain—Telbivudine—hepatitis B	0.00144	0.00318	CcSEcCtD
Carvedilol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00143	0.00316	CcSEcCtD
Carvedilol—CYP1A2—blood—hepatitis B	0.00142	0.00802	CbGeAlD
Carvedilol—Dizziness—Entecavir—hepatitis B	0.00141	0.00313	CcSEcCtD
Carvedilol—CYP1A1—blood—hepatitis B	0.00141	0.00791	CbGeAlD
Carvedilol—Rhinitis—Lamivudine—hepatitis B	0.0014	0.00309	CcSEcCtD
Carvedilol—Abdominal pain—Telbivudine—hepatitis B	0.00139	0.00308	CcSEcCtD
Carvedilol—Body temperature increased—Telbivudine—hepatitis B	0.00139	0.00308	CcSEcCtD
Carvedilol—Hypoaesthesia—Lamivudine—hepatitis B	0.00139	0.00307	CcSEcCtD
Carvedilol—Pharyngitis—Lamivudine—hepatitis B	0.00138	0.00306	CcSEcCtD
Carvedilol—Vomiting—Entecavir—hepatitis B	0.00136	0.00301	CcSEcCtD
Carvedilol—CYP2C9—blood—hepatitis B	0.00135	0.00761	CbGeAlD
Carvedilol—Rash—Entecavir—hepatitis B	0.00135	0.00299	CcSEcCtD
Carvedilol—Dermatitis—Entecavir—hepatitis B	0.00135	0.00298	CcSEcCtD
Carvedilol—ADRA1A—liver—hepatitis B	0.00135	0.00759	CbGeAlD
Carvedilol—Headache—Entecavir—hepatitis B	0.00134	0.00297	CcSEcCtD
Carvedilol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00133	0.00294	CcSEcCtD
Carvedilol—Erythema multiforme—Lamivudine—hepatitis B	0.00132	0.00292	CcSEcCtD
Carvedilol—Rash—Adefovir Dipivoxil—hepatitis B	0.00132	0.00291	CcSEcCtD
Carvedilol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00131	0.00291	CcSEcCtD
Carvedilol—ADRA2A—blood—hepatitis B	0.00131	0.00738	CbGeAlD
Carvedilol—Headache—Adefovir Dipivoxil—hepatitis B	0.00131	0.00289	CcSEcCtD
Carvedilol—ADRA2C—liver—hepatitis B	0.00128	0.00723	CbGeAlD
Carvedilol—CYP2E1—blood—hepatitis B	0.00128	0.00722	CbGeAlD
Carvedilol—Nausea—Entecavir—hepatitis B	0.00127	0.00281	CcSEcCtD
Carvedilol—Asthenia—Telbivudine—hepatitis B	0.00126	0.00279	CcSEcCtD
Carvedilol—Immune system disorder—Lamivudine—hepatitis B	0.00126	0.00279	CcSEcCtD
Carvedilol—Mediastinal disorder—Lamivudine—hepatitis B	0.00126	0.00278	CcSEcCtD
Carvedilol—Pruritus—Telbivudine—hepatitis B	0.00124	0.00275	CcSEcCtD
Carvedilol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00124	0.00274	CcSEcCtD
Carvedilol—PTGS1—blood—hepatitis B	0.00123	0.00695	CbGeAlD
Carvedilol—Alopecia—Lamivudine—hepatitis B	0.00123	0.00273	CcSEcCtD
Carvedilol—Malnutrition—Lamivudine—hepatitis B	0.00121	0.00269	CcSEcCtD
Carvedilol—Diarrhoea—Telbivudine—hepatitis B	0.0012	0.00266	CcSEcCtD
Carvedilol—Flatulence—Lamivudine—hepatitis B	0.0012	0.00265	CcSEcCtD
Carvedilol—Tension—Lamivudine—hepatitis B	0.00119	0.00264	CcSEcCtD
Carvedilol—Nervousness—Lamivudine—hepatitis B	0.00118	0.00261	CcSEcCtD
Carvedilol—Back pain—Lamivudine—hepatitis B	0.00117	0.0026	CcSEcCtD
Carvedilol—Muscle spasms—Lamivudine—hepatitis B	0.00117	0.00258	CcSEcCtD
Carvedilol—Dizziness—Telbivudine—hepatitis B	0.00116	0.00257	CcSEcCtD
Carvedilol—Ill-defined disorder—Lamivudine—hepatitis B	0.00113	0.00249	CcSEcCtD
Carvedilol—Anaemia—Lamivudine—hepatitis B	0.00112	0.00248	CcSEcCtD
Carvedilol—Vomiting—Telbivudine—hepatitis B	0.00112	0.00247	CcSEcCtD
Carvedilol—CYP1A2—liver—hepatitis B	0.00111	0.00627	CbGeAlD
Carvedilol—Angioedema—Lamivudine—hepatitis B	0.00111	0.00245	CcSEcCtD
Carvedilol—Rash—Telbivudine—hepatitis B	0.00111	0.00245	CcSEcCtD
Carvedilol—Dermatitis—Telbivudine—hepatitis B	0.00111	0.00245	CcSEcCtD
Carvedilol—Headache—Telbivudine—hepatitis B	0.0011	0.00244	CcSEcCtD
Carvedilol—CYP1A1—liver—hepatitis B	0.0011	0.00619	CbGeAlD
Carvedilol—Malaise—Lamivudine—hepatitis B	0.00109	0.00242	CcSEcCtD
Carvedilol—Vertigo—Lamivudine—hepatitis B	0.00109	0.00241	CcSEcCtD
Carvedilol—Syncope—Lamivudine—hepatitis B	0.00109	0.00241	CcSEcCtD
Carvedilol—Leukopenia—Lamivudine—hepatitis B	0.00109	0.0024	CcSEcCtD
Carvedilol—Loss of consciousness—Lamivudine—hepatitis B	0.00107	0.00236	CcSEcCtD
Carvedilol—Cough—Lamivudine—hepatitis B	0.00106	0.00234	CcSEcCtD
Carvedilol—CYP2C9—liver—hepatitis B	0.00106	0.00595	CbGeAlD
Carvedilol—Convulsion—Lamivudine—hepatitis B	0.00105	0.00233	CcSEcCtD
Carvedilol—Nausea—Telbivudine—hepatitis B	0.00104	0.00231	CcSEcCtD
Carvedilol—Arthralgia—Lamivudine—hepatitis B	0.00103	0.00229	CcSEcCtD
Carvedilol—Chest pain—Lamivudine—hepatitis B	0.00103	0.00229	CcSEcCtD
Carvedilol—Myalgia—Lamivudine—hepatitis B	0.00103	0.00229	CcSEcCtD
Carvedilol—CYP3A4—blood—hepatitis B	0.00103	0.00581	CbGeAlD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00103	0.00227	CcSEcCtD
Carvedilol—Discomfort—Lamivudine—hepatitis B	0.00102	0.00226	CcSEcCtD
Carvedilol—CYP2D6—blood—hepatitis B	0.00101	0.00571	CbGeAlD
Carvedilol—Dry mouth—Lamivudine—hepatitis B	0.00101	0.00224	CcSEcCtD
Carvedilol—CYP2E1—liver—hepatitis B	0.001	0.00564	CbGeAlD
Carvedilol—Confusional state—Lamivudine—hepatitis B	0.000999	0.00221	CcSEcCtD
Carvedilol—Oedema—Lamivudine—hepatitis B	0.00099	0.00219	CcSEcCtD
Carvedilol—Anaphylactic shock—Lamivudine—hepatitis B	0.00099	0.00219	CcSEcCtD
Carvedilol—Infection—Lamivudine—hepatitis B	0.000984	0.00218	CcSEcCtD
Carvedilol—Shock—Lamivudine—hepatitis B	0.000974	0.00216	CcSEcCtD
Carvedilol—Thrombocytopenia—Lamivudine—hepatitis B	0.00097	0.00215	CcSEcCtD
Carvedilol—Skin disorder—Lamivudine—hepatitis B	0.000962	0.00213	CcSEcCtD
Carvedilol—Hyperhidrosis—Lamivudine—hepatitis B	0.000957	0.00212	CcSEcCtD
Carvedilol—Anorexia—Lamivudine—hepatitis B	0.000944	0.00209	CcSEcCtD
Carvedilol—Hypotension—Lamivudine—hepatitis B	0.000925	0.00205	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000902	0.002	CcSEcCtD
Carvedilol—Insomnia—Lamivudine—hepatitis B	0.000896	0.00198	CcSEcCtD
Carvedilol—Paraesthesia—Lamivudine—hepatitis B	0.000889	0.00197	CcSEcCtD
Carvedilol—Dyspnoea—Lamivudine—hepatitis B	0.000883	0.00195	CcSEcCtD
Carvedilol—Somnolence—Lamivudine—hepatitis B	0.00088	0.00195	CcSEcCtD
Carvedilol—Dyspepsia—Lamivudine—hepatitis B	0.000872	0.00193	CcSEcCtD
Carvedilol—Decreased appetite—Lamivudine—hepatitis B	0.000861	0.00191	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000855	0.00189	CcSEcCtD
Carvedilol—Fatigue—Lamivudine—hepatitis B	0.000854	0.00189	CcSEcCtD
Carvedilol—Pain—Lamivudine—hepatitis B	0.000847	0.00187	CcSEcCtD
Carvedilol—Constipation—Lamivudine—hepatitis B	0.000847	0.00187	CcSEcCtD
Carvedilol—Feeling abnormal—Lamivudine—hepatitis B	0.000816	0.00181	CcSEcCtD
Carvedilol—Gastrointestinal pain—Lamivudine—hepatitis B	0.00081	0.00179	CcSEcCtD
Carvedilol—CYP3A4—liver—hepatitis B	0.000806	0.00454	CbGeAlD
Carvedilol—CYP2D6—liver—hepatitis B	0.000793	0.00447	CbGeAlD
Carvedilol—Urticaria—Lamivudine—hepatitis B	0.000787	0.00174	CcSEcCtD
Carvedilol—Body temperature increased—Lamivudine—hepatitis B	0.000783	0.00173	CcSEcCtD
Carvedilol—Abdominal pain—Lamivudine—hepatitis B	0.000783	0.00173	CcSEcCtD
Carvedilol—ABCB1—blood—hepatitis B	0.00073	0.00411	CbGeAlD
Carvedilol—Hypersensitivity—Lamivudine—hepatitis B	0.00073	0.00162	CcSEcCtD
Carvedilol—Asthenia—Lamivudine—hepatitis B	0.000711	0.00157	CcSEcCtD
Carvedilol—Pruritus—Lamivudine—hepatitis B	0.000701	0.00155	CcSEcCtD
Carvedilol—Diarrhoea—Lamivudine—hepatitis B	0.000678	0.0015	CcSEcCtD
Carvedilol—Dizziness—Lamivudine—hepatitis B	0.000655	0.00145	CcSEcCtD
Carvedilol—Vomiting—Lamivudine—hepatitis B	0.00063	0.00139	CcSEcCtD
Carvedilol—Rash—Lamivudine—hepatitis B	0.000624	0.00138	CcSEcCtD
Carvedilol—Dermatitis—Lamivudine—hepatitis B	0.000624	0.00138	CcSEcCtD
Carvedilol—Headache—Lamivudine—hepatitis B	0.00062	0.00137	CcSEcCtD
Carvedilol—Nausea—Lamivudine—hepatitis B	0.000588	0.0013	CcSEcCtD
Carvedilol—ABCB1—liver—hepatitis B	0.000571	0.00321	CbGeAlD
Carvedilol—PTGS1—Metabolism—GOT2—hepatitis B	4.8e-05	0.00013	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CCR5—hepatitis B	4.76e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CCR5—hepatitis B	4.74e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—IL2—hepatitis B	4.73e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CCR5—hepatitis B	4.72e-05	0.000127	CbGpPWpGaD
Carvedilol—XDH—Metabolism—ALB—hepatitis B	4.71e-05	0.000127	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CCR5—hepatitis B	4.71e-05	0.000127	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CCR5—hepatitis B	4.7e-05	0.000127	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GGT2—hepatitis B	4.65e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CCR5—hepatitis B	4.64e-05	0.000125	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL2—hepatitis B	4.62e-05	0.000125	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GGT2—hepatitis B	4.61e-05	0.000124	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL10—hepatitis B	4.6e-05	0.000124	CbGpPWpGaD
Carvedilol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	4.5e-05	0.000121	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—F2—hepatitis B	4.48e-05	0.000121	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—F2—hepatitis B	4.47e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—F2—hepatitis B	4.44e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—ALB—hepatitis B	4.43e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—IL2—hepatitis B	4.42e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CCR5—hepatitis B	4.39e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—F2—hepatitis B	4.38e-05	0.000118	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CYP2A6—hepatitis B	4.32e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CCR5—hepatitis B	4.32e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CCR5—hepatitis B	4.23e-05	0.000114	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	4.22e-05	0.000114	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.18e-05	0.000113	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GGT1—hepatitis B	4.15e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—GOT1—hepatitis B	4.15e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—F2—hepatitis B	4.15e-05	0.000112	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GGT1—hepatitis B	4.15e-05	0.000112	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—GOT1—hepatitis B	4.15e-05	0.000112	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKR1B1—hepatitis B	4.11e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—F2—hepatitis B	4.08e-05	0.00011	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—F2—hepatitis B	4.07e-05	0.00011	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—F2—hepatitis B	4.05e-05	0.000109	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TP53—hepatitis B	4.05e-05	0.000109	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—F2—hepatitis B	4.04e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—F2—hepatitis B	4.03e-05	0.000109	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—F2—hepatitis B	3.98e-05	0.000107	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYP2A6—hepatitis B	3.97e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL10—hepatitis B	3.96e-05	0.000107	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	3.94e-05	0.000106	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GGT2—hepatitis B	3.94e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CCR5—hepatitis B	3.93e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GOT2—hepatitis B	3.91e-05	0.000105	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CCR5—hepatitis B	3.84e-05	0.000104	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.78e-05	0.000102	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—F2—hepatitis B	3.77e-05	0.000102	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP2A6—hepatitis B	3.74e-05	0.000101	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—IL6—hepatitis B	3.71e-05	0.0001	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—F2—hepatitis B	3.71e-05	0.0001	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TGFB1—hepatitis B	3.69e-05	9.95e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—F2—hepatitis B	3.63e-05	9.78e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL10—hepatitis B	3.61e-05	9.75e-05	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PTEN—hepatitis B	3.59e-05	9.69e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—IL2—hepatitis B	3.59e-05	9.68e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GOT2—hepatitis B	3.59e-05	9.68e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL10—hepatitis B	3.58e-05	9.66e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CCR5—hepatitis B	3.57e-05	9.62e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL10—hepatitis B	3.53e-05	9.53e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.49e-05	9.41e-05	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	3.48e-05	9.37e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TGFB1—hepatitis B	3.45e-05	9.3e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GOT2—hepatitis B	3.38e-05	9.13e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GOT1—hepatitis B	3.37e-05	9.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—GGT1—hepatitis B	3.37e-05	9.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—F2—hepatitis B	3.37e-05	9.09e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL10—hepatitis B	3.34e-05	9.02e-05	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—IL2—hepatitis B	3.31e-05	8.93e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—F2—hepatitis B	3.29e-05	8.88e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL10—hepatitis B	3.29e-05	8.88e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKR1B1—hepatitis B	3.17e-05	8.55e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GGT1—hepatitis B	3.1e-05	8.36e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GOT1—hepatitis B	3.1e-05	8.36e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR5—hepatitis B	3.07e-05	8.29e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—F2—hepatitis B	3.06e-05	8.25e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGT2—hepatitis B	3.04e-05	8.2e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—hepatitis B	3.04e-05	8.2e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—hepatitis B	3.02e-05	8.14e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—hepatitis B	3.01e-05	8.11e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—hepatitis B	2.99e-05	8.07e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP2A6—hepatitis B	2.99e-05	8.06e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—hepatitis B	2.95e-05	7.96e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL10—hepatitis B	2.92e-05	7.88e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GOT1—hepatitis B	2.92e-05	7.88e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GGT1—hepatitis B	2.92e-05	7.88e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—hepatitis B	2.84e-05	7.66e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP2A6—hepatitis B	2.82e-05	7.6e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR5—hepatitis B	2.8e-05	7.56e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TGFB1—hepatitis B	2.8e-05	7.55e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—hepatitis B	2.79e-05	7.53e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.79e-05	7.53e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR5—hepatitis B	2.78e-05	7.49e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—hepatitis B	2.75e-05	7.41e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR5—hepatitis B	2.74e-05	7.39e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—hepatitis B	2.74e-05	7.39e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—hepatitis B	2.73e-05	7.36e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—hepatitis B	2.72e-05	7.34e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL10—hepatitis B	2.72e-05	7.33e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—hepatitis B	2.72e-05	7.32e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—hepatitis B	2.71e-05	7.32e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GOT2—hepatitis B	2.7e-05	7.29e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—hepatitis B	2.68e-05	7.23e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.66e-05	7.18e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	2.65e-05	7.15e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—F2—hepatitis B	2.64e-05	7.12e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CTNNB1—hepatitis B	2.63e-05	7.1e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CTNNB1—hepatitis B	2.63e-05	7.09e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.6e-05	7.02e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR5—hepatitis B	2.59e-05	6.99e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CDKN1A—hepatitis B	2.57e-05	6.94e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CDKN1A—hepatitis B	2.57e-05	6.92e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PTEN—hepatitis B	2.57e-05	6.92e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTEN—hepatitis B	2.56e-05	6.91e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NFKB1—hepatitis B	2.55e-05	6.89e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR5—hepatitis B	2.55e-05	6.88e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NFKB1—hepatitis B	2.55e-05	6.87e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GOT2—hepatitis B	2.55e-05	6.87e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—hepatitis B	2.54e-05	6.84e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GOT2—hepatitis B	2.53e-05	6.81e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—hepatitis B	2.5e-05	6.73e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—hepatitis B	2.44e-05	6.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—F2—hepatitis B	2.4e-05	6.48e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP2A6—hepatitis B	2.39e-05	6.44e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—F2—hepatitis B	2.38e-05	6.42e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—F2—hepatitis B	2.35e-05	6.34e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GGT1—hepatitis B	2.33e-05	6.29e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GOT1—hepatitis B	2.33e-05	6.29e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—hepatitis B	2.31e-05	6.22e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—hepatitis B	2.27e-05	6.12e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR5—hepatitis B	2.27e-05	6.11e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—F2—hepatitis B	2.22e-05	6e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.22e-05	6e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—hepatitis B	2.22e-05	5.98e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—hepatitis B	2.21e-05	5.96e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—hepatitis B	2.21e-05	5.95e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GOT1—hepatitis B	2.2e-05	5.93e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GGT1—hepatitis B	2.2e-05	5.93e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—F2—hepatitis B	2.19e-05	5.91e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GGT1—hepatitis B	2.18e-05	5.88e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GOT1—hepatitis B	2.18e-05	5.88e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GOT2—hepatitis B	2.16e-05	5.82e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TGFB1—hepatitis B	2.13e-05	5.74e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TGFB1—hepatitis B	2.12e-05	5.73e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR5—hepatitis B	2.11e-05	5.68e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—hepatitis B	2.06e-05	5.56e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.99e-05	5.36e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—F2—hepatitis B	1.94e-05	5.25e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GOT1—hepatitis B	1.86e-05	5.02e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GGT1—hepatitis B	1.86e-05	5.02e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP2A6—hepatitis B	1.84e-05	4.97e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—F2—hepatitis B	1.81e-05	4.87e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—hepatitis B	1.79e-05	4.84e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—hepatitis B	1.78e-05	4.79e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—hepatitis B	1.77e-05	4.77e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—hepatitis B	1.75e-05	4.72e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—hepatitis B	1.75e-05	4.71e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CTNNB1—hepatitis B	1.72e-05	4.63e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.7e-05	4.58e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTEN—hepatitis B	1.69e-05	4.55e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTEN—hepatitis B	1.68e-05	4.54e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CDKN1A—hepatitis B	1.68e-05	4.52e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTEN—hepatitis B	1.67e-05	4.51e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GOT2—hepatitis B	1.67e-05	4.49e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NFKB1—hepatitis B	1.66e-05	4.49e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—hepatitis B	1.65e-05	4.45e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—hepatitis B	1.62e-05	4.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—hepatitis B	1.61e-05	4.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—hepatitis B	1.6e-05	4.33e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—hepatitis B	1.6e-05	4.32e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—hepatitis B	1.6e-05	4.32e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—hepatitis B	1.6e-05	4.31e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—hepatitis B	1.58e-05	4.27e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—hepatitis B	1.58e-05	4.25e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CTNNB1—hepatitis B	1.56e-05	4.22e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—hepatitis B	1.55e-05	4.19e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CTNNB1—hepatitis B	1.55e-05	4.18e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CTNNB1—hepatitis B	1.53e-05	4.12e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CDKN1A—hepatitis B	1.53e-05	4.12e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTEN—hepatitis B	1.52e-05	4.11e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NFKB1—hepatitis B	1.52e-05	4.09e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CDKN1A—hepatitis B	1.51e-05	4.08e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTEN—hepatitis B	1.51e-05	4.07e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NFKB1—hepatitis B	1.5e-05	4.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—hepatitis B	1.5e-05	4.04e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CDKN1A—hepatitis B	1.49e-05	4.03e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—hepatitis B	1.49e-05	4.02e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTEN—hepatitis B	1.49e-05	4.02e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NFKB1—hepatitis B	1.48e-05	4e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—hepatitis B	1.47e-05	3.98e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—hepatitis B	1.47e-05	3.96e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CTNNB1—hepatitis B	1.45e-05	3.9e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GOT1—hepatitis B	1.44e-05	3.88e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GGT1—hepatitis B	1.44e-05	3.88e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CTNNB1—hepatitis B	1.42e-05	3.84e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CDKN1A—hepatitis B	1.41e-05	3.81e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTEN—hepatitis B	1.41e-05	3.8e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NFKB1—hepatitis B	1.4e-05	3.78e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CDKN1A—hepatitis B	1.39e-05	3.75e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTEN—hepatitis B	1.39e-05	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TGFB1—hepatitis B	1.39e-05	3.74e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NFKB1—hepatitis B	1.38e-05	3.72e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTEN—hepatitis B	1.37e-05	3.69e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—hepatitis B	1.31e-05	3.53e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—hepatitis B	1.3e-05	3.52e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CTNNB1—hepatitis B	1.26e-05	3.41e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TGFB1—hepatitis B	1.26e-05	3.41e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTEN—hepatitis B	1.26e-05	3.39e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TGFB1—hepatitis B	1.25e-05	3.37e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—hepatitis B	1.24e-05	3.35e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TGFB1—hepatitis B	1.24e-05	3.33e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CDKN1A—hepatitis B	1.24e-05	3.33e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTEN—hepatitis B	1.23e-05	3.32e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NFKB1—hepatitis B	1.23e-05	3.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—hepatitis B	1.22e-05	3.28e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—hepatitis B	1.21e-05	3.27e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTEN—hepatitis B	1.19e-05	3.2e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CTNNB1—hepatitis B	1.17e-05	3.17e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—hepatitis B	1.17e-05	3.15e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TGFB1—hepatitis B	1.17e-05	3.15e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—hepatitis B	1.16e-05	3.13e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TGFB1—hepatitis B	1.15e-05	3.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CDKN1A—hepatitis B	1.15e-05	3.1e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTEN—hepatitis B	1.15e-05	3.09e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—hepatitis B	1.14e-05	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NFKB1—hepatitis B	1.14e-05	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—hepatitis B	1.04e-05	2.82e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—hepatitis B	1.04e-05	2.8e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—hepatitis B	1.03e-05	2.78e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TGFB1—hepatitis B	1.02e-05	2.76e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—hepatitis B	1.02e-05	2.74e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—hepatitis B	9.91e-06	2.67e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—hepatitis B	9.62e-06	2.6e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—hepatitis B	9.51e-06	2.57e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TGFB1—hepatitis B	9.49e-06	2.56e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTEN—hepatitis B	9.47e-06	2.55e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—hepatitis B	9.47e-06	2.55e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—hepatitis B	9.43e-06	2.54e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—hepatitis B	9.31e-06	2.51e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTEN—hepatitis B	8.92e-06	2.41e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTEN—hepatitis B	8.85e-06	2.39e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—hepatitis B	8.81e-06	2.38e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—hepatitis B	8.67e-06	2.34e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—hepatitis B	8.41e-06	2.27e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—hepatitis B	7.81e-06	2.11e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—hepatitis B	7.7e-06	2.08e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—hepatitis B	7.65e-06	2.06e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTEN—hepatitis B	7.56e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—hepatitis B	7.15e-06	1.93e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTEN—hepatitis B	5.83e-06	1.57e-05	CbGpPWpGaD
